FTH

NASDAQ 已收盘

Faeth Therapeutics

8.69 USD
▼-0.03-0.34%
盘后 10.96 0.00%
2026-11-19
市值
$203.65M
市盈率
—
EPS
-24.64
股息率
—
52 周区间
7.45 – 42.14
成交量
470.82K
Beta
-0.18
目标价
56.15
52W 低 7.4552W 高 42.14
价格走势

公司简介

Faeth Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. It offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company’s pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early ...